SULFOXIMINE ACTIVATORS OF SEROTONIN RECEPTORS

Methods of treating a stress-related disease or disorder such as PTSD and mood/depressive disorder, inducing neurite outgrowth, or inducing structural neuroplasticity, comprising administering to a subject a composition comprising an effective amount of a compound that does not have an agonist activ...

Full description

Saved in:
Bibliographic Details
Main Authors Gibbs, Alan C, Khan, Tanweer A, Short, Glenn F, Perni, Robert B
Format Patent
LanguageEnglish
Published 07.11.2024
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Methods of treating a stress-related disease or disorder such as PTSD and mood/depressive disorder, inducing neurite outgrowth, or inducing structural neuroplasticity, comprising administering to a subject a composition comprising an effective amount of a compound that does not have an agonist activity on 5-HT2A serotonin receptor are disclosed. Also disclosed are pharmaceutical compositions comprising compound not having an agonist activity on 5-HT2A serotonin receptor and a pharmaceutically acceptable carrier.
Bibliography:Application Number: US202318532940